Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lodestone Biomedical has developed an implantable biosensor system using functionalized magnetic nanoparticles to enable real-time, longitudinal monitoring of immune modulators within the tumor microenvironment. This allows researchers to detect treatment responses earlier during immuno-oncology drug development. The system is currently validated in animal models and supported by NIH SBIR funding. Products are intended strictly for research use at this time; no clinical trial results or approved therapeutics exist[2][3][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lodestone Biomedical.